Kaletra (lopinavir/ritonavir)

Kaletra (Lopinavir/Ritonavir)

This page in under construction. Please send comments and suggestions to mpalmedo@cptech.org

MSF Seeks Access to New Kaletra Formulation in Developing Countries

Exchange of Letters Between MSF and Abbott Laboratories
- March 23, 2006. Nicholas de Torrente, Executive Director of MSF-USA. Open Response to Abbott Laboratories’ Letter to MSF on March 17, 2006.
- March 17, 2006. Heather L. Mason, Vice President of International Marketing for Abbott. Open Letter to Nicholas de Torrente, Executive Director of MSF-USA.
- March 15, 2006. Nicholas de Torrente, Executive Director of MSF-USA. Open Letter to Miles While, Chairman and CEO of Abbott Laboratories.
- March 13, 2006. Heather L. Mason, Vice President of International Marketing for Abbott. Open Letter to Daniel Berman, MSF.
Supporting Documents from MSF
- April 27, 2006. More Empty Promises: Abbott Fails to Supply Critical New AIDS Drug Formulation to Developing Countries.
- April 5, 2006. Sign-On Letter to Abbott CEO Miles White sponsored by MSF.
- March 15, 2006. Press Release. Access Denied to Crucial New HIV/AIDS Medicines - Patients in Developing Countries Forced to Settle for Second-Best.
- March 14, 2006. Briefing note. Abbott's New and Improved Kaletra: Only in the US... But What About the Rest of the World?
Other Statements
- April 28, 2006. Abbott Promises Shareholders Expanded AIDS Drug Access, But Fails to Deliver: Activists Protest.
- April 6, 2006. Student Global AIDS Campaign. Response to Abbott Announcement of Kaletra Registration and Pricing in Global South.
- April 4, 2006. Abbott Press Release. Abbott Files for Registration of Innovative Formulation for the Treatment of HIV In South Africa - Abbott to Maintain Current Lopinavir/Ritonavir Pricing for New Non-Refrigerated Formulation Throughout Africa and the Least Developed Countries.
News Stories
- April 5, 2006. UN Integrated Regional Information Networks. South Africa: Heat-Resistant Aids Drug On Way.
- March 17, 2006. United Press International. HIV drug should be cheaper, group says.
- March 15, 2006. Tume Ahemba for Reuters. Relief group seeks access to new HIV drug in Africa.
- March 15, 2006. South African Press Association. 'Give Africa new Aids drug.'

CPTech Documents

CPTech Page on Abbott Laboratories' 400% Ritonavir Price Hike. Includes information on the Essential inventions request for a compulsory license for ritonavir.
March 25, 2006. James Love. Statement to NIH on Norvir March-In Request.

General Information

Abbott's Page on Kaletra

Return to: CPTech Home -> Main IP Page -> IP and Healthcare -> HIV/AIDS Drugs